Sonde Health, a global leader in voice AI-based health technology, announced a collaboration with Qualcomm Technologies, Inc. to enable Sonde’s embedded vocal biomarker platform on devices powered b...

Sonde collaborates with Qualcomm to place vocal biomarker technology in small-footprint chipsets for fast-growing personal device segments
BOSTON: Sonde Health, a global leader in voice AI-based health technology, announced a collaboration with Qualcomm Technologies, Inc. to enable Sonde’s embedded vocal biomarker platform on devices powered by the Snapdragon® AR1 Gen 1, processor. This collaboration enables smart glasses and AR glasses to deliver ambient, privacy and security-focused wellness monitoring through the analysis of everyday speech-without the need for explicit voice commands or user prompts.
Sonde’s technology passively detects and analyzes subtle vocal patterns to generate fitness scores across multiple wellness domains, including stress, mental fitness, cognitive fitness, and respiratory health. By embedding Sonde’s lightweight SDK directly into AI-powered devices, smart glasses and AR glasses will be able to provide real-time insights and personalized wellness support without disrupting a user’s daily routine.
“Collaborating with Qualcomm Technologies allows us to optimize our technology at the chipset level, enabling truly seamless and scalable integration for smart and AR glasses manufacturers,” said David Liu, CEO of Sonde Health. “With Sonde’s platform, Snapdragon AR1-powered devices can go beyond entertainment and connectivity-they can become proactive wellness companions that help the underlying conversational AI understand how you’re doing and help you feel your best.”
Sonde’s key features and benefits include:
Sonde’s integration with Snapdragon AR1 platforms will enable smart glasses and AR glasses to continuously add value through future updates and the deployment of new health biomarkers. This collaboration pushes towards a new benchmark for ambient wellness technology in the rapidly growing smart glasses and AR glasses industries.
About Sonde Health
Sonde Health is the global leader in voice AI health tracking and data insights. Sonde's vocal biomarker API/SDK serves enterprise applications and devices spanning consumer wellness to population health. Leveraging a best-in-class voice data set and clinical research with over 1.2 million samples from 85,000+ individuals across four continents, Sonde uses advanced audio signal processing, speech science, and machine learning to sense and analyze subtle vocal changes due to changes in a person's physiology to provide key insights into health and well-being. www.sondehealth.com
Snapdragon and Qualcomm branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries. Snapdragon is a trademark or registered trademark of Qualcomm Incorporated.
Fonte: Business Wire
Alaa Abdul Nabi, Vice President, Sales International at RSA presents the innovations the vendor brings to Cybertech as part of a passwordless vision for…
G11 Media's SecurityOpenLab magazine rewards excellence in cybersecurity: the best vendors based on user votes
Always keeping an European perspective, Austria has developed a thriving AI ecosystem that now can attract talents and companies from other countries
Successfully completing a Proof of Concept implementation in Athens, the two Italian companies prove that QKD can be easily implemented also in pre-existing…
Deepgram, the world’s most realistic and real-time Voice AI platform, today announced integration of its enterprise-grade speech-to-text (STT) and text-to-speech…
Deepgram, the world’s most realistic and real-time Voice AI platform, today announced native integration with Amazon SageMaker AI, delivering streaming,…
NeurIPS 2025, Booth #732 – MathWorks, the leading developer of mathematical computing software, will showcase how engineers and scientists can use MATLAB®…
In Lower West Side, Chicago section, first bullet point should read: Total BFCM Weekend Volume: $8.4M (instead of Total BFCM Weekend Volume: $49M). The…